And that’s 14: More (and more) Mori retractions, as Japanese cancer journal pulls three papers

Naoki Mori

The steady drip-drip-dripping sound you hear from the cancer literature these days comes from the stream of retractions involving studies by Naoki Mori, the now jobless scientist whose work on cancer viruses appears to be evaporating before our eyes.

Cancer Science, which used to be called the Japanese Journal of Cancer Research,  has retracted three more of Mori’s papers, each of which, according to the journal, contained multiple unreliable images. That brings the tally of retractions involving Mori’s articles to 14 by our count, an impressive number by any measure. Mori has more than 50 papers to his name, however, so it’s possible that the number of retractions will grow.

Here are the latest retractions: Continue reading And that’s 14: More (and more) Mori retractions, as Japanese cancer journal pulls three papers

Inability to reproduce Dutch grad student’s data prompts two retractions from the cancer lit

We are watching an intriguing case out of the Netherlands, involving a young researcher whose dubious results have led to the retraction of a pair of papers.

The retracted articles, which appeared in 2008 in Cancer Research and the British Journal of Cancer, come from the lab of the prominent Dutch scientist Ed Roos, of the Netherlands Cancer Institute in Amsterdam. Both papers addressed the actions of certain chemokine receptors — molecules on cell surfaces that interact with blood proteins involved in the immune response — on the behavior of tumor cells.

The first author on each paper was Joost Meijer, at the time a graduate student in Roos’ shop.

The retraction notices contain essentially the same information, although in the case of the BJC article — “Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo” — the letter is quite personal. Dated Jan. 4, 2011, it reads: Continue reading Inability to reproduce Dutch grad student’s data prompts two retractions from the cancer lit

Clinical Infectious Diseases retracts antibiotic guidelines after posting uncorrected version

A few days after Clinical Infectious Diseases published a set of guidelines for using antibiotics in patients with cancer and dangerously compromised immune systems, we noticed that they had retracted the paper. The Medline notice read: Continue reading Clinical Infectious Diseases retracts antibiotic guidelines after posting uncorrected version

Sixth Bulfone-Paus retraction accepted

Silvia Bulfone-Paus

A journal has accepted the sixth retraction of a paper co-authored by Silvia Bulfone-Paus, the Research Centre Borstel announced late last week. Borstel has been investigating allegations that two of Bulfone-Paus’s former postdocs manipulated images.

The paper, in the Scandinavian Journal of Immunology, is titled Continue reading Sixth Bulfone-Paus retraction accepted

Researcher found to have deceived colleague — and perhaps sabotaged others — decides to study plagiarism

Jatinder Ahluwalia apparently did some pretty bad things as a researcher at University College London. As we reported in November, in an investigation related to a Nature retraction, a research misconduct panel at UCL found that:

Ahluwalia “renumbered the files to deceive [another coauthor,] Professor [Lucie] Clapp as to the results of his patch clamping experiments,” adulterated his reagents so his results would look better, and sabotaged his colleagues’ work.

The panel said that the file renumbering charge was proven “beyond reasonable doubt,” and “that on the balance of probabilities it was highly confident”  that the other two charges had been proven. It also concluded unanimously that Ahluwalia had acted alone.

So he knows from research misconduct, in several of its forms. There’s one that he doesn’t seem to have engaged in, however, and that’s the one he’s decided to study in his new position at the University of East London: Continue reading Researcher found to have deceived colleague — and perhaps sabotaged others — decides to study plagiarism

Resurrection? Paper about Jesus and the flu remains online, not marked as retracted

In August, we reported on the retraction of a paper in Virology Journal about whether a woman allegedly cured by Jesus Christ had the flu or some other ailment. The original paper was published on July 21, 2010. On August 11, after a flurry of criticism from various bloggers, the journal’s editor, Robert Garry, apologized for publishing it in a comment. On the 13th, the journal published a retraction notice.

But as an eagle-eyed Retraction Watch reader has pointed out, the original paper, and its abstract, both remain online, without any suggestion that the paper was retracted. We found that puzzling, so we called Garry, of Tulane’s department of microbiology and immunology. Continue reading Resurrection? Paper about Jesus and the flu remains online, not marked as retracted

A lightning-fast JNCI retraction shows how science should work

The retraction last week of a commentary in the Journal of the National Cancer Institute (JNCI) looks like a nice — and very quick — example of self-correction in science.

The commentary, “Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk prediction,” was co-authored by Stuart Baker and Daniel Sargent, and published in the December 1, 2010 issue. The journal published the retraction, and a letter that contained the re-analysis that led to it, on January 12.

The retraction notice: Continue reading A lightning-fast JNCI retraction shows how science should work

Remote Sensing pulls soil scattering paper lifted from earlier thesis

Remote Sensing has retracted an article whose author decided that a previously published thesis said it best—and decided not mention that inconvenient fact.

The article, “Study of soil scattering coefficients in combination with diesel for a slightly rough surface in the cj band,” was published in late December 2009. The author was Alireza Taravat Najafabadi, a researcher in the department of geoinformatics at the University of Pune.  At some point in 2010, the journal received word that the paper likely contained plagiarism.

From the retraction notice, issued earlier this month: Continue reading Remote Sensing pulls soil scattering paper lifted from earlier thesis

Four more Bulfone-Paus paper retractions accepted

About two weeks ago, we reported on the first retraction of a paper co-authored by Silvia Bulfone-Paus, whose work at her Research Center Borstel lab is being investigated for misconduct. On Friday, Borstel announced that journals had accepted four more retractions of papers by Bulfone-Paus’s group.

Three of those papers are in the Journal of Immunology (citations according to Thomson Scientific’s Web of Knowledge): Continue reading Four more Bulfone-Paus paper retractions accepted

Fraud by Naoki Mori claims another paper, this one in a journal whose board he sits on

Late last month we wrote about a handful of retractions involving Naoki Mori, a promising Japanese cancer researcher who appears to have built a CV with the help of fabricated evidence.

The fraud earned Mori a 10-year publishing ban from the American Society of Microbiology, which publishes Infection and Immunity. There were two other retractions in Blood, from the American Society of Hematology.

Now, another journal has joined the party. Continue reading Fraud by Naoki Mori claims another paper, this one in a journal whose board he sits on